A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery Eine Mischung aus Aminophyllin und Heparin plus Nitroglycerin kann Bradykardie während Rotations-Atherektomie der A. coronaria dextra und des dominanten Ramus circumflexus vermindern
Herz, cilt.48, sa.6, ss.480-486, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 48 Sayı: 6
- Basım Tarihi: 2023
- Doi Numarası: 10.1007/s00059-023-05195-1
- Dergi Adı: Herz
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE
- Sayfa Sayıları: ss.480-486
- Anahtar Kelimeler: Aminophylline, Atherectomy, Atrioventricular block, Bradycardia, Pacemaker
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: Rotational atherectomy (RA) may cause bradyarrhythmias and transitory atrioventricular block when performed in the right coronary artery (RCA) or a dominant circumflex (CX) coronary artery. However, there are no studies of a solution that can prevent coronary flow deterioration and bradycardia complications that may occur during RA. We aimed to create an alternative rota-flush solution to minimize the risk of bradycardia and complete atrioventricular block (AVB) that can occur during RA. Materials and methods: The study comprised 60 patients who were randomly divided into two groups: 30 received rotaphylline (= 240 mg aminophylline, 10,000 U unfractionated heparin, and 2000 mcg nitroglycerin to 1000 mL saline), and 30 received the traditional rota-flush (= 10,000 U unfractionated heparin, 2000 mcg nitroglycerin, and 1000 mL saline). The incidence of bradycardia or high-grade AVB (HAVB) during RA, coronary slow-flow phenomenon or no-reflow phenomenon, and coronary spasm were the primary endpoints of the study. Procedure success and RA-related procedural complications were secondary endpoints. Results: The use of rotaphylline was an independent predictor of bradycardia and HAVB after accounting for all other factors (OR: 0.47, 95% CI: 0.24–0.79, p < 0.001). Lesion length (OR: 2.17, 95% CI: 1.24–3.04, p < 0.001), burr-to-artery ratio (OR: 0.59, 95% CI: 0.39–1.68, p < 0.001), and total run duration (OR: 0.79, 95% CI: 0.35–1.43, p < 0.001) were additional independent predictors. Conclusion: Bradycardia and the development of HAVB may be avoided by rotaphylline intracoronary infusion during RA applied to the RCA and dominant CX lesions. Multicenter studies including sizable patient populations should be conducted to validate the present findings.